Approved Weight-Management Medicines (TGA)

Metabolic or diet drugs encompass medications that affect metabolic processes or are used for weight management, including appetite suppressants, fat absorption inhibitors, metabolic stimulants, and newer pharmaceutical approaches to weight management. In Australia, weight loss medications require prescribing by medical practitioners or authorised healthcare professionals under defined circumstances, with some products carrying significant cardiac and psychiatric side effect profiles requiring careful patient selection and monitoring. Healthcare providers prescribing metabolic or diet drugs face professional liability for inadequate patient assessment (particularly cardiovascular screening), failure to monitor for adverse effects, inappropriate prescribing to patients with contraindications, and inadequate counselling about lifestyle modification as primary treatment. Professional indemnity insurance typically covers liability arising from appropriate prescribing of metabolic or diet drugs as part of comprehensive weight management, though insurers may scrutinise prescribing practices in this area due to historical concerns about inappropriate prescribing. Coverage considerations include prescribing within product indications and evidence-based guidelines, appropriate patient assessment and monitoring, documented lifestyle and dietary counselling, and avoidance of prescribing solely for cosmetic purposes. Some insurers exclude or limit coverage for "script clinics" primarily focused on dispensing diet medications without comprehensive medical assessment, viewing such practices as outside acceptable professional standards. Healthcare providers prescribing metabolic or diet drugs require robust protocols for patient assessment, monitoring, and continuation criteria.

Metabolic or diet drugs encompass medications that affect metabolic processes or are used for weight management, including appetite suppressants, fat absorption inhibitors, metabolic stimulants, and newer pharmaceutical approaches to weight management. In Australia, weight loss medications require prescribing by medical practitioners or authorised healthcare professionals under defined circumstances, with some products carrying significant cardiac and psychiatric side effect profiles requiring careful patient selection and monitoring. Healthcare providers prescribing metabolic or diet drugs face professional liability for inadequate patient assessment (particularly cardiovascular screening), failure to monitor for adverse effects, inappropriate prescribing to patients with contraindications, and inadequate counselling about lifestyle modification as primary treatment. Professional indemnity insurance typically covers liability arising from appropriate prescribing of metabolic or diet drugs as part of comprehensive weight management, though insurers may scrutinise prescribing practices in this area due to historical concerns about inappropriate prescribing. Coverage considerations include prescribing within product indications and evidence-based guidelines, appropriate patient assessment and monitoring, documented lifestyle and dietary counselling, and avoidance of prescribing solely for cosmetic purposes. Some insurers exclude or limit coverage for "script clinics" primarily focused on dispensing diet medications without comprehensive medical assessment, viewing such practices as outside acceptable professional standards. Healthcare providers prescribing metabolic or diet drugs require robust protocols for patient assessment, monitoring, and continuation criteria.